Risk factors of Alzheimer's disease - A review;Risikofaktoren der Alzheimer-Demenz

Fortschritte der Neurologie Psychiatrie

Volumn 64, Issue 11, 1996, Pages 425-432

  Aksari, Pinar ^a   Stoppe, Gabriela ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; APOLIPOPROTEIN E4; ESTROGEN;

ADULT; AGE; AGED; ALZHEIMER DISEASE; CHROMOSOME 19; COPING BEHAVIOR; DEPRESSION; EDUCATION; FEMALE; HEAD INJURY; HUMAN; MALE; REVIEW; RISK FACTOR;

EID: 0029907497     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996588     Document Type: Review

References (94)

1. Adolfsson, R., G. Bucht, F. Lithner, B. Winblad: Hypoglycemia in Alzheimer's disease. Acta Med. Scand. 208 (1980) 387-388
2. Amaducci, L. A., L. Fratiglioni, W. A. Rocca et al.: Risk factors for clinically diagnosed Alzheimer's disease: A case-control study of an Italian population. Neurology 36 (1986) 922-931
3. American Psychiatric Association Task Force on Nomenclature and Statistics: Diagnostic and statistical manual of mental disorders. Third Edition, Revised. American Psychiatric Association, Washington, DC 1987
4. Aronson, M. K., W. L. Ooi, H. Morgenstern et al.: Women, myocardial infarction and dementia in the very old. Neurology 40 (1990) 1102-1106
5. Aronson, M. K., W. L. Ooi, D. L. Geva, D. Masur, A. Blau, W. Frishman: Dementia. Age-dependent incidence, prevalence and mortality in the old. Arch. Intern. Med. 151 (1991) 989-992
6. Bachman, D. L., P. A. Wolf, R. Linn et al.: Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 42 (1992) 115-119
7. Bachman, D. L., P. A. Wolf, R. Linn et al.: Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham study. Neurology 43 (1993) 515-519
8. Bäckman, L.: Memory training and memory improvements in Alzheimer's disease: rules and exceptions. Acta Neurol. Scand. 139 (1992) 84-89
9. Bauer, J., M. Berger: Neuropathologische, immunologische und psychobiologische Aspekte der Alzheimer-Demenz. Fortschr. Neurol. Psychiat. 61 (1993) 225-240
10. Breitner, J. C. S., E. A. Murphy: Twin studies of Alzheimer's disease: II. Some predictions under a genetic model. Am. J. Med. Genet. 44 (1992) 628-634
11. Breitner, J. C. S., B. A. Gau, K. A. Welsh, B. L. Plassman, W. M. McDonald, M. J. Helms, J. C. Anthony: Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44 (1994) 227-232
12. Brenner, D. E., W. A. Kukull, A. Stergachis, G. van Belle, J. D. Bowen, W. C. McCormick, L. Ten, E. B. Larson: Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am. J. Epidemiol. 140 (1994) 262-267
13. Breteler, M. M. B., C. M. van Duijn, V. Chandra et al.: Medical history and the risk of Alzheimer's disease: a collaborative reanalysis of case-control studies. Int. J. Epidemiol. 20 (1991) 36-42
14. Broe, G. A., A. S. Henderson, H. Creasey et al.: A case-control study of Alzheimer's disease in Australia. Neurology 40 (1990) 1698 -1707
15. Bucht, G., R. Adolfsson, F. Lithner, B. Winblad: Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer type. Acta Med. Scand. 213 (1983) 387-392
16. Burger, P. C., F. S. Vogel: The development of the pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am. J. Pathol. 73 (1973) 457-476
17. Cederblad, M., L. Dahlin, O. Hagnell, K. Hansson: Intelligence and temperament as protective factors for mental health. A cross-sectional and prospective epidemiological study. Arch. Psychiatry Clin. Neurosci. 245 (1995) 11-19
18. Chandra, V., V. Philipose, P. A. Bell, A. Lazaroff, B. S. Schoenberg: Case-control study of late onset "probable Alzheimer's disease". Neurology 37 (1987) 1295-1300
19. Cooper, B., H. Bickel: Prävalenz und Inzidenz von Demenzerkrankungen in der Altenbevölkerung. Nervenarzt 60 (1989) 472-482
20. Copeland, J. R., I. A. Davidson, M. E. Dewey et al.: Alzheimer's disease, other dementias, depression and pseudodementia: prevalence, incidence and three-year outcome in Liverpool. Brit. J. Psychiat. 161 (1992) 230-239
21. Corder, E. H., A. M. Saunders, N. J. Risch et al.: Protective effect of Apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7 (1994) 180-184
22. Czech, C., H. Förstl, F. Hentschel, U. Monning, C. Besthorn, C. Geiger-Kabisch, H. Sattel, C. Masters, K. Beyreuther: Apolipoprotein E-4 gene dose in clinically diagnosed Alzheimer's disease: prevalence, plasma cholesterol levels and cerebrovascular change. Eur. Arch. Psychiatry Clin. Neurosci. 243 (1994) 291-292
23. Delabar, J. M., D. Goldgaber, Y. Lamour et al.: β-Amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science 235 (1987) 1390-1392
24. Ermini-Fünfschilling, D., H. B. Stähelin: Gibt es eine Prävention der Demenz? Z. Gerontol. 26 (1993) 446-452
25. Förstl, H., C. Czech, H. Sattel, C. Geiger-Kabisch, C. Besthorn, S. Kreger, U. Mönning, T. Hartmann, C. Masters, K. Beyreuther: Apolipoprotein E und Alzheimer-Demenz. Nervenarzt 65 (1994) 780-786
26. Fratiglione, L., A. Ahlbom, M. Vitanen, B. Winblad: Risk factors for late-onset Alzheimer's disease: a population based case control-study. Ann. Neurol. 33 (1993) 258-266
27. Frecker, M. F., W. E. Pryse-Philipps, H. R. Strong: Immunological associations in familial and non-familial Alzheimer patients and their families. Can. J. Neurol. Sci. 21 (1994) 112-119
28. Frisoni, G. B., S. Govoni, C. Geroldi, A. Bianchetti, L. Calabresi, G. Franceschini, M. Trabucchi: Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann. Neurol. 37 (1995) 596-604
29. Gibb, W. R. G.: Dementia and Parkinson's disease. Brit. J. Psychiatry 154 (1989) 596-614
30. Goate, A., M.-C. Chartier-Harlin, M. Mullan et al.: Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349 (1991) 704-706
31. Graves, A. B., E. White, T. D. Koepsell, B. V. Reifler, G. V. Belle, E. B. Larson: The association between aluminium-containing products and Alzheimer's disease. J. Clin. Epidemiol. 43 (1990) 35-44
32. Graves, A. B., E. White, T. D. Koepsell et al.: The association between head trauma and Alzheimer's disease. Am. J. Epidemiol. 131 (1991) 491
33. Graves, A. B., C. M. van Duijn, V. Chandra et al.: Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM risk factors research group. Int. J. Epidemiol. 20 (1991) 48-57
34. Henderson, A. S., A. F. Jorm, A. E. Korten, H. Creasey, E. McCusker, G. A. Broe, W. Longley, J. C. Anthony: Environmental risk factors for Alzheimer's disease: their relationship to age of onset and to familial or sporadic types. Psychol. Med. 22 (1992) 429-436
35. Heston, L. L.: Alzheimer's disease, trisomy 21, and myeloproliferative disorders. Associations suggesting a genetic diathesis. Science 196 (1977) 322-323
36. Heyman, A., W. E. Wilkinson, J. A. Stafford, M. J. Helms, A. H. Sigmon, T. Weinberg: Alzheimer's disease. A study of epidemiological aspects. Ann. Neurol. 15 (1984) 335-341
37. Hill, L. R., M. Klauber, R. Katzman et al.: Functional status, education, and the diagnosis of dementia in the Shanghai survey. Neurology 43 (1993) 138-145
38. st-degree relatives of patients with Alzheimer's disease. Neurology 39 (1989) 1589-1592
39. Jorm, A. F., A. E. Korten, A. S. Henderson: The prevalence of dementia: A quantitative integration of the literature. Acta psychiatr. scand. 76 (1987) 465-479
40. Jorm, A. F., C. M. van Duijn, V. Chandra et al.: Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20 (1991) 43-47
41. Katzman, R.: Alzheimer's disease. N. Engl. J. Med. 314 (1986) 964-973
42. Katzman, R.: Views and reviews: education and the prevalence of dementia and Alzheimer's disease. Neurology 43 (1993) 13-20
43. Katzman, R., C. Kawas: The epidemiology of dementia and Alzheimer's disease. In: Terry, R. D., R. Katzman, K. L. Bick (ed.): Alzheimer's disease. Raven Press, New York (1994) 105-122
44. Kokmen, E., C. M. Beard, V. Chandra, K. P. Offord, B. S. Schoenberg, D. J. Ballard: Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 41 (1991) 1393-1397
45. Koller, W. C., S. L. Glatt, J. P. Hubble et al.: Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann. Neuro. 37 (1995) 242-245
46. Kondo, K., M. Niino, K. Shido: A case-control study of Alzheimer's disease in Japan - Significance of life-styles. Dementia 5 (1994) 314-326
47. Kurz, A., N. Lautenschlager, M. Haupt, R. Zimmer, B. von Thülen, K. Altland, H. Lauter, U. Müller: Das Apolipoprotein E-..4-Allelist ein Risikofaktor für die Alzheimer-Krankheit mit frühem und spätem Beginn. Nervenarzt 65 (1994) 774-779
48. Lee, P. N.: Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 13 (1994) 131-144
49. Mahley, R. W.: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
50. Mayeux, R., R. Ottman, M.-X. Tang, L. Noboa-Bauza, K. Marder, B. Gurland, Y. Stern: Genetic susceptibility and head injury as risk factors for Alzheimer's disease among community-dwelling elderly persons and their first-degree relatives. Ann. Neurol. 33 (1993) 494-501
51. McGeer, P. L., E. McGerr, J. Rogers, J. Sibley: Antiinflammatory drugs and Alzheimer disease. Lancet II (1990) 1037
52. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price, E. M. Stadlan: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
53. McLachlan, D. R., T. P. Kruck, W. J. Lukiw, S. S. Krishnan: Would decreased aluminium ingestion reduce the incidence of Alzheimer's disease? Can. Med. Assoc. J. 145 (1991) 793-804
54. Mendez, M. F., K. L. Underwood, B. A. Zander, A. R. Mastri, J. H. Sung, W. H. Frey: Risk factors in Alzheimer's disease: A clinopathologic study. Neurology 42 (1992) 770-775
55. Mortimer, J. A., L. R. French, J. T. Hutton, L. M. Schumann: Head injury as a risk factor for Alzheimer's disease. Neurology 35 (1985) 264-267
56. Mowry, B. J., P. W. Burvill: A study of mild dementia in the community using a wide range of diagnostic criteria. Brit. J. Psychiat. 153 (1988) 328-334
57. Mülhauser, I., R. Kimmerle, M. Berger: Langzeittherapie mit Sexualhormonen zur Krankheitsverhütung und Lebensverlängerung in der Postmenopause. arznei-telegramm 4 (1995) 37-44
58. Mullan, M., F. Crawford, K. Axelman et al.: A pathogenetic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nature Genetics 1 (1992) 345-347
59. Murrel, J., M. Farlow, B. Ghetti, M. D. Benson: A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254 (1991) 97-99
60. Paganini-Hill, A., V. W. Henderson: Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140 (1994) 256-261
61. Payani, H., K. R. Montee, J. A. Kaye, T. D. Bird, C.-E. Yu, E. M. Wijsman, G. D. Schellenberg: Alzheimer's disease, Apolipoprotein E4 and gender. J. Am. Med. Assoc. 271 (1994) 1316
62. Poirier, J., J. Davignon, D. Bouthillier, S. Kogan, P. Bertrand, S. Gauthier: Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 342 (1993) 697-699
63. Rebeck, G. W., J. S. Reiter, D. K. Strickland, B. T. Hyman: Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 11 (1993) 575-580
64. Rifat, S. L., M. R. Eastwood, D. R. Crapper-McLachlan, P. N. Corey: Effect of exposure of miners to aluminium powder. Lancet 336 (1990) 1162-1165
65. Roberts, G. W., D. Allsop, C. Bruton: The occult aftermath of boxing. Neuropathol. Appl. Neurobiol. 15 (1989) 273-274
66. Rocca, W. A.: Frequency, Distribution, and risk factors for Alzheimer's disease. Nurs. Clin. North. Am. 29 (1994) 101-111
67. Rocca, W. A., C. M. van Duijn, D. Clayton et al.: Maternal age and Alzheimer's disease: a collaborative re-analysis of case-control studies. Int. J. Epidemiol. 20 (1991) 21-27
68. Ron, M. A., B. K. Toone, M. E. Garralda, W. A. Lishman: Diagnostic accuracy in presenile dementia. Brit. J. Psychiat 134 (1979) 161-168
69. Rorsman, B., O. Hagnell, J. Lanke et al.: Prevalence and incidence of senile and multi-infarct dementia in the Lundby study: a comparison between the time periods 1947-1957 and 1957-1972. Neuropsychobiology 15 (1986) 122-129
70. Roses, A. D., M. A. Pericak-Vance, C. M. Clark et al.: Linkage studies of late-onset familial Atzheimer's disease. Adv. Neurol. 51 (1990) 185-196
71. Roses, A. D., A. M. Saunders, W. J. Strittmatter, M. A. Pericak-Vance, D. Schmechel: Association of apolipoprotein E allele E4 with late onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) A192
72. Schellenberg, G. D., T. D. Bird, E. M. Wijsman et al: Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258 (1992) 668-671
73. Schoenberg, B. S., D. A. Anderson, A. F. Haerer: Severe dementia prevalence and clinical features in a biracial US population. Arch. Neurol. 42 (1985) 740-743
74. Schupf, N., D. Kapell, J. H. Lee, R. Ottman, R. Mayeux: Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet 344 (1994) 353-356
75. Seemann, P., F. Laccone, J. Reiss, G. Stoppe: Absence of mutations in the apolipoprotein E (ApoE) gene of patients with Alzheimer's disease. Human Mutations 5 (1995) 103-104
76. Shalat, S. L., B. Seltzer, C. Pidcock, E. L. Baker Jr.: Risk factors for Alzheimer's disease: A case-control study. Neurology 37 (1987) 1630-1633
77. Silverman, J. M., K. Raiford, S. Edland, G. Fillenbaum, J. C. Morris, C. M. Clark, W. Kukull, A. Heyman: The consortium to establish a registry for Alzheimer's disease (CERAD). Part VI. Family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls. Neurology 44 (1994) 1253-1259
78. Soininen, H., O. P. Heinonen: Clinical and Etiological Aspects of Senile Dementia. Eur. Neurol. 21 (1982) 401-410
79. Sorbi, S., B. Nacmias, P. Forleo, S. Latorraca, L. Gobbini, L. Bracco: ApoE allele frequencies in Italien sporadic and familial Alzheimer's disease. Neurosci. Lett. 177 (1994) 100-102
80. Sparks, D. L., J. C. Hunsaker, S. W. Scheff, R. F. Kryscic, J. L. Henson, W. R. Markesbery: Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol. Aging 11 (1990) 601-608
81. St. George-Hyslop, P. H., J. L. Haines, E. Rogaev et al.: Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nature Genetics 2 (1992) 330-334
82. St. Georg-Hyslop, P. H., R. E. Tanzi, R. J. Polinsky et al.: Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease. Science 238 (1987) 664-666
83. Stoppe, G., J. Staedt: Die frühe diagnostische Differenzierung primär dementer von primär depressiven Syndromen im Alter ein Beitrag zur Pseudodemenzdiskussion. Fortschr. Neurol. Psychiat. 61 (1993) 172-182
84. Sulkava, R., J. Wikstrom, A. Aromaa et al.: Prevalence of severe dementia in Finland. Neurology 35 (1985) 1025-1029
85. Ueda, K., H. Kawano, Y. Hasuo, M. Fujishima: Prevalence and etiology of dementia in a Japanese community. Stroke 23 (1992) 798-803
86. Uterman, G.: Apolipoprotein E polymorphism in health and disease. Am. Heart. J. 113 (1987) 433-440
87. van Duijn, C. M., T. Stijnen, A. Hofman: Risk factors for Alzheimer's disease: overview of the EURODEM collaborative reanalysis of case-controll studies. Int. J. Epidemiol. 20 (1991a) 4-12
88. van Duijn, C. M., D. Clayton, V. Chandra et al.: Familial aggregation of Alzheimer's disease and related disorders: a collaborative reanalysis of case-control studies. Int. J. Epidemiol. 20 (1991b) 13-20
89. van Duijn, C. M., P. de Knijff, M. Cruts, A. Wehnert, L. M. Havekes, A. Hofman, C. van Broeckhoven: Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nature Genet. 7 (1994) 74-78
90. van Duijn, C. M., P. de Knijff, A. Wehnert, J. de Voecht, J. B. Bronzova, L. M. Havekes, A. Hofman, C. van Broeckhoven: The apolipoprotein E2 Allele is associated with an increased risk of early-onset Alzheimer's disease and a reduced survival. Ann. Neurol. 37 (1995) 606-610
91. Whalley, L. J., A. D. Carothers, S. Collyer, R. Demey, A. Frackiewics: A study of familial factors in Alzheimer's disease. Brit. J. Psychiat. 140 (1982) 249-256
92. White, D. M., W. T. Longstreth, L. Rosenstock, H. J. Claypoole, C. A. Bodkin, B. D. Townes: Neurologic syndrome in 25 workers from an aluminium smelting plant. Arch. Intern. Med. 152 (1992) 1443-1448
93. Whitehouse, P. J.: Parkinson's disease and Alzheimer's disease. New neurochemical parallels. Movement Disorders 4 (1989) 57-61
94. Zhang, M., R. Katzman, H. Jin: The prevalence of dementia and Alzheimer's disease (AD) in Shanghai, China: impact on age, gender and education. Ann. Neurol. 27 (1990) 428-437